BIM
GSK icon

Bogle Investment Management’s GSK GSK Stock Holding History

Bogle Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-85,203
Closed -$5M – 305
2019
Q4 		$5M Sell
85,203
-158,727
-65% -$8.83M 0.47% 80
2019
Q3 		$13M Hold
243,930
– – 1.12% 14
2019
Q2 		$12.2M Buy
243,930
+480
+0.2% +$24.1K 0.96% 37
2019
Q1 		$12.7M Buy
+243,450
New +$12.2M 0.97% 31

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bogle Investment Management's GSK Position: Q1 2020 in Review

Bogle Investment Management sold out of GSK (GSK) in Q1 2020, closing a stake of 85,203 shares — an estimated $5M sold.

Bogle Investment Management first reported a position in GSK in Q1 2019 and held it in 4 quarters. The position peaked at $13M in Q3 2019. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

  • Bogle Investment Management reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
  • Bogle Investment Management sold 85,203 GSK shares in Q1 2020, an estimated $5M.
  • Bogle Investment Management first reported a position in GSK in Q1 2019 and held it in 4 quarters.
  • Bogle Investment Management's GSK position peaked at $13M in Q3 2019.
  • 817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Bogle Investment Management's 13F filing for Q1 2020, filed 13 May 2020.